TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

Figure 2

Patients exhibiting a CR of multiple lung metastases and liver metastases after TILs plus anti-PD1 therapy. (a) The patient achieved a CR of multiple lung metastases (the yellow arrows) after 3 months of immunotherapy. (b) The patient achieved a CR of multiple liver metastases (the yellow arrows) after 4 months of immunotherapy.

(a)

(b)